Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087343510> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2087343510 endingPage "41" @default.
- W2087343510 startingPage "38" @default.
- W2087343510 abstract "The antidiabetic activities of the aqueous (AqEx) and ethanolic (AlEx) extracts of Cleome droserifolia (Forssk.) Del., were tested in cultured C2C12 skeletal muscle cells and 3T3-L1 adipocytes. An 18-h treatment with the AqEx increased basal glucose uptake by 33% [insulin equivalent (IE) = 1.3 ± 0.04] in muscle cells comparable to a 25.5% increase caused by 100 nM insulin (IE = 1 ± 0.03). Fractionation of the tested AqEx yielded hexane (HxFr), chloroform (ClFr) and ethyl acetate (EtFr) fractions which exerted 38, 52 and 35% increase in the glucose uptake corresponding to an IE of 1.5 ± 0.06, 2.0 ± 0.04 and 1.4 ± 0.04, respectively. Only the ClFr and EtFr accelerated the triglyceride accumulation [rosiglitazone equivalent (RE) was 0.9 ± 0.13 and 0.63 ± 0.12, respectively] in pre-adipocytes undergoing differentiation comparably with 10 μM rosiglitazone. Six terpenoids (C1–C6) and three flavonol glycosides (F1–F3) were isolated from the active ClFr and EtFr, respectively, and identified. C5, C2 and C4 had an IE of 0.86 ± 0.05, 1.01 ± 0.04 and 0.9 ± 0.08, while F1, F2 and F3 gave an IE of 1.3 ± 0.05, 2.3 ± 0.05 and 2.0 ± 0.04, respectively. We could conclude that the reported antihyperglycemic activity of Cleome droserifolia is attributed to significant insulin-like effects in peripheral tissues, and that compounds F2 and F3, being highly active, could be used as bioactive markers to standardize the C. droserifolia herbal extract." @default.
- W2087343510 created "2016-06-24" @default.
- W2087343510 creator A5010518239 @default.
- W2087343510 creator A5049455533 @default.
- W2087343510 creator A5054999608 @default.
- W2087343510 date "2011-12-01" @default.
- W2087343510 modified "2023-10-03" @default.
- W2087343510 title "Determination of bioactive markers in Cleome droserifolia using cell-based bioassays for antidiabetic activity and isolation of two novel active compounds" @default.
- W2087343510 cites W1969261151 @default.
- W2087343510 cites W1985422490 @default.
- W2087343510 cites W2001119469 @default.
- W2087343510 cites W2037256523 @default.
- W2087343510 cites W2071580797 @default.
- W2087343510 cites W2107476304 @default.
- W2087343510 cites W2109125214 @default.
- W2087343510 cites W2124583149 @default.
- W2087343510 cites W2166927346 @default.
- W2087343510 doi "https://doi.org/10.1016/j.phymed.2011.07.003" @default.
- W2087343510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21890334" @default.
- W2087343510 hasPublicationYear "2011" @default.
- W2087343510 type Work @default.
- W2087343510 sameAs 2087343510 @default.
- W2087343510 citedByCount "27" @default.
- W2087343510 countsByYear W20873435102012 @default.
- W2087343510 countsByYear W20873435102013 @default.
- W2087343510 countsByYear W20873435102014 @default.
- W2087343510 countsByYear W20873435102015 @default.
- W2087343510 countsByYear W20873435102016 @default.
- W2087343510 countsByYear W20873435102017 @default.
- W2087343510 countsByYear W20873435102018 @default.
- W2087343510 countsByYear W20873435102019 @default.
- W2087343510 countsByYear W20873435102020 @default.
- W2087343510 countsByYear W20873435102021 @default.
- W2087343510 countsByYear W20873435102022 @default.
- W2087343510 countsByYear W20873435102023 @default.
- W2087343510 crossrefType "journal-article" @default.
- W2087343510 hasAuthorship W2087343510A5010518239 @default.
- W2087343510 hasAuthorship W2087343510A5049455533 @default.
- W2087343510 hasAuthorship W2087343510A5054999608 @default.
- W2087343510 hasConcept C134018914 @default.
- W2087343510 hasConcept C170493617 @default.
- W2087343510 hasConcept C185592680 @default.
- W2087343510 hasConcept C206103511 @default.
- W2087343510 hasConcept C2777866211 @default.
- W2087343510 hasConcept C2778163477 @default.
- W2087343510 hasConcept C2778913445 @default.
- W2087343510 hasConcept C2779306644 @default.
- W2087343510 hasConcept C2779858419 @default.
- W2087343510 hasConcept C2780152017 @default.
- W2087343510 hasConcept C55493867 @default.
- W2087343510 hasConcept C86803240 @default.
- W2087343510 hasConcept C98274493 @default.
- W2087343510 hasConceptScore W2087343510C134018914 @default.
- W2087343510 hasConceptScore W2087343510C170493617 @default.
- W2087343510 hasConceptScore W2087343510C185592680 @default.
- W2087343510 hasConceptScore W2087343510C206103511 @default.
- W2087343510 hasConceptScore W2087343510C2777866211 @default.
- W2087343510 hasConceptScore W2087343510C2778163477 @default.
- W2087343510 hasConceptScore W2087343510C2778913445 @default.
- W2087343510 hasConceptScore W2087343510C2779306644 @default.
- W2087343510 hasConceptScore W2087343510C2779858419 @default.
- W2087343510 hasConceptScore W2087343510C2780152017 @default.
- W2087343510 hasConceptScore W2087343510C55493867 @default.
- W2087343510 hasConceptScore W2087343510C86803240 @default.
- W2087343510 hasConceptScore W2087343510C98274493 @default.
- W2087343510 hasIssue "1" @default.
- W2087343510 hasLocation W20873435101 @default.
- W2087343510 hasLocation W20873435102 @default.
- W2087343510 hasOpenAccess W2087343510 @default.
- W2087343510 hasPrimaryLocation W20873435101 @default.
- W2087343510 hasRelatedWork W1970094770 @default.
- W2087343510 hasRelatedWork W2042616790 @default.
- W2087343510 hasRelatedWork W2072061777 @default.
- W2087343510 hasRelatedWork W2084097844 @default.
- W2087343510 hasRelatedWork W2097282105 @default.
- W2087343510 hasRelatedWork W2100514340 @default.
- W2087343510 hasRelatedWork W2108073447 @default.
- W2087343510 hasRelatedWork W2144763061 @default.
- W2087343510 hasRelatedWork W2909479645 @default.
- W2087343510 hasRelatedWork W3214671004 @default.
- W2087343510 hasVolume "19" @default.
- W2087343510 isParatext "false" @default.
- W2087343510 isRetracted "false" @default.
- W2087343510 magId "2087343510" @default.
- W2087343510 workType "article" @default.